Correspondence 0001493152-24-039687 from BirchBioMed Inc. (CIK 0001670747)

BirchBioMed Inc. (CIK 0001670747)
Date: Oct. 7, 2024 · CIK: 0001670747 · Accession: 0001493152-24-039687

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-12475

Date

October 4, 2024

Author

BirchBioMed

Form

CORRESP

Company

BirchBioMed Inc. (CIK 0001670747)

Letter

BirchBioMed Inc.

Kingscross Drive

King City, Ontario, Canada L7B 1E6

October 7, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Re: BirchBioMed Inc.

Offering Statement on Form 1-A/A

Filed October 4, 2024

File No. 024-12475

Ladies and Gentlemen:

BirchBioMed Inc., a corporation incorporated under the laws of the Province of British Columbia, Canada, hereby requests qualification of the offering statement on Form 1-A, as amended by the Form 1-A/A filed on September 26, 2024, and the Form 1-A/A filed on October 4, 2024 (File No. 024-12475), at 4:30 p.m. Eastern Time on October 8, 2024, or as soon thereafter as practicable.

If you have any questions or comments, please contact Alexander McClean of Harter Secrest & Emery LLP at (585) 231-1248.

Sincerely,
BirchBioMed
Inc.

Show Raw Text

CORRESP
1
filename1.htm

BirchBioMed
Inc.

130
Kingscross Drive

King
City, Ontario, Canada L7B 1E6

October
7, 2024

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    BirchBioMed
    Inc.

    Offering
    Statement on Form 1-A/A

    Filed
    October 4, 2024

    File
    No. 024-12475

Ladies
and Gentlemen:

BirchBioMed
Inc., a corporation incorporated under the laws of the Province of British Columbia, Canada, hereby requests qualification of the offering
statement on Form 1-A, as amended by the Form 1-A/A filed on September 26, 2024, and the Form 1-A/A filed on October 4, 2024 (File
No. 024-12475), at 4:30 p.m. Eastern Time on October 8, 2024, or as soon thereafter as practicable.

If
you have any questions or comments, please contact Alexander McClean of Harter Secrest & Emery LLP at (585) 231-1248.

    Sincerely,

    BirchBioMed
    Inc.

    By:
    /s/
Mark S. Miller

    Mark
    S. Miller

    Chief
    Executive Officer

SecProbe.io